SCHEMBL29453740

SCHEMBL29453740

N#CC1(Cc2ccccc2Cl)CCN(C(=O)c2cccnc2-c2ccncc2)CC1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP46A1 Q9Y6A2 11/20 0.59
▸ CYP3A4 P08684 1/20 0.59
▸ CYP2C8 P10632 1/20 0.59
▸ CYP2C9 P11712 1/20 0.59
▸ CYP2C19 P33261 1/20 0.59
▸ HTR2A P28223 1/20 0.44
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ THRB P10828 1/20 0.38
▸ P2RX7 Q99572 1/20 0.37
▸ HCRTR1 O43613 1/20 0.37
▸ HCRTR2 O43614 1/20 0.37
▸ GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22719467 1.00 CYP46A1 (0.59) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719239 0.89 CYP46A1 (0.59) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453717 0.89 CYP46A1 (0.59) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453711 0.89 CYP46A1 (0.59) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719460 0.89 CYP46A1 (0.59) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453767 0.87 CYP46A1 (0.74) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719476 0.87 CYP46A1 (0.74) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719295 0.86 CYP46A1 (0.56) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453797 0.86 CYP46A1 (0.56) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719284 0.86 CYP46A1 (0.68) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3976186-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USE Sage Therapeutics, Inc. (US) 2022-04-06 — — EP disclosed
Send feedback